Alpha Paradigm Partners’s Fate Therapeutics FATE Stock Holding History

Alpha Paradigm Partners’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$1.27M	Buy
2022 Q2	$1.09M	Buy